In temporal lobe epilepsy models, PBM has been observed to mitigate neurodegeneration and cognitive decline by upregulating synaptic-related proteins, such as neuroligin-3, indicating its role in enhancing synaptic connectivity and cognitive function (144). This evidence concerns the gene NLGN3 and temporal lobe epilepsy.